logo

SKU: 188-10436-SAF-RB

Anti-HLA-DR Antibody (MHC II), Sodium Azide Free

Blue Ice

Specifications

Specification Details
Species Reactivity Human, Monkey
Application FC, IF
Label Unconjugated
Gene ID 3122
Accession No. P01903
Immunogen Spleen cells from a patient with hairy cell leukemia were used as the immunogen for the HLA-DR antibody.
Background mAb IPO-1 defines the antigen, which appears on B cell progenitors following HLA-DR and preceding CD1, CD19, CD22, CD37 and cym. It is expressed on resting B cells and than reappears and persists in cytoplasm and on cell surface until cytoplasmic Ig appears. It is a useful antibody for diagnostics of neoplasms of B cell origins. It reacts with human B cell lines Daudi, Raji, Namalva, EB-3, RPMI-8226 (5% of cells). The mAb does not label T cell lines, blood granulocytes, thymocytes or bone marrow stromal fibroblasts. No significant changes are detected after PHA or ConA stimulation while LPS and PWM stimulated cultures after 18-48h show decreased number of antigen-positive cells but in final terms of cultivation antigen is expressed again. This mAb labels B cell leukemias and some lymphomas. Hairy cell leukemia strongly reacts and 7% of B cell CLL and some B-NHL were also positive. IPO-1 reacts with AMML cells and in a majority of Hodgkin's disease cases a significant percentage of affected lymph node cells were detected.
Primary / Secondary Primary Antibody
Isotype Mouse IgG3, kappa
Concentration 1 mg/ml in 1X PBS, BSA free, sodium azide free
Host Mouse
Catalog Number
188-10436-SAF-RB
Name
Anti-HLA-DR Antibody (MHC II), Sodium Azide Free
Price(100 ug)
Pack Size
100 ug
← Back to products